NCT03231111

Brief Summary

The Effectiveness of Using Preventive Multimedia Teaching Program in Lung Cancer Women Receiving Targeted Therapy on Skin-Related Quality of Life

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable lung-cancer

Timeline
Completed

Started Jul 2017

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 13, 2017

Completed
12 days until next milestone

Study Start

First participant enrolled

July 25, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 27, 2017

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2018

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2018

Completed
Last Updated

July 27, 2017

Status Verified

July 1, 2017

Enrollment Period

11 months

First QC Date

July 13, 2017

Last Update Submit

July 25, 2017

Conditions

Lung Cancer

Outcome Measures

Primary Outcomes (1)

  • skindex-29

    Skin-Related Quality of Life

    average of 1 month

Study Arms (2)

traditional group

NO INTERVENTION

Multimedia group

EXPERIMENTAL
Other: Preventive Multimedia Teaching Program

Interventions

Preventive Multimedia Teaching ProgramOTHER

Preventive Multimedia Teaching Program

Multimedia group

Eligibility Criteria

Age20 Years - 80 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients older than 20 years of age.
  • The first time to accept the target drug treatment (Iressa, Tarceva) treatment, diagnosis of lung cancer third or fourth stage of the women.
  • There are computer equipment at home to play the disc.
  • can speak, write, read Chinese, clear consciousness, no cognitive impairment.
  • In the medical center of Taipei, a medical department, medical or surgical clinic for treatment.

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, Taiwan

RECRUITING

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Central Study Contacts

YA-PEI LIANG

CONTACT

+886-975582026annie8165@gmail.com

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 13, 2017

First Posted

July 27, 2017

Study Start

July 25, 2017

Primary Completion

July 1, 2018

Study Completion

December 31, 2018

Last Updated

July 27, 2017

Record last verified: 2017-07

Locations

TW(1)